Chronic obstructive pulmonary disease (COPD) is an increasingly important cause of
morbidity and mortality, pathological features of which are pulmonary inflammation and …

The inhaled route is critical for the administration of drugs to treat patients suffering from
COPD, but there is still an unmet need for new and innovative inhalers to address some …

Chronic obstructive pulmonary disease (COPD) is a progressive and irreversible airflow
limitation with extreme economic and social burden. It is estimated that over the next two …

Since chronic obstructive pulmonary disease (COPD) is characterized by progressive airflow
obstruction, inhaled bronchodilators form the mainstay of treatment. A variety of new inhaled …

Introduction: The number of pulmonary diseases that are effectively treated by aerosolized
medicine continues to grow. Areas covered: These diseases include chronic obstructive …

Asthma and chronic obstructive pulmonary disease (COPD) are obstructive lung diseases
which are characterized by chronic inflammation and an increase in mucus production, and …

Introduction Proper device selection is crucial for the clinical results of inhalation therapy.
However, none of the available devices fully conforms to the requirements for delivering …

Current guidelines recommend inhalation therapy as the preferred route of drug
administration for treating patients with chronic obstructive pulmonary disease (COPD) …

Chronic obstructive pulmonary disease (COPD) is the most common lung disease, carrying
a significant mortality and morbidity. None of the therapeutic interventions currently available …

Dry powder inhalers (DPIs) have been available for delivering drugs to the lungs for over 30
years. In the last decade there has been a big increase in DPI development, resulting partly …